USFDA

1) Alembic gets USFDA nod for Vilazodone Hydrochloride tablets used to  

    treat depression 

Source: 

https://www.thehindubusinessline.com/companies/alembic-gets-usfda-nod-for-vilazodone-hydrochloride-tablets-used-to-treat-depression/article30555550.ece

 

2) Alembic gets USFDA nod for Tizanidine hydrochloride capsules used to      treat spasticity

Source:  

https://www.outlookindia.com/newsscroll/alembic-gets-usfda-nod-for-tizanidine-hydrochloride-capsules-used-to-treat-spasticity/1708727

3) FDA approves Blueprint's stomach cancer therapy priced at $32,000 per 

    month

Source: 

https://kfgo.com/news/articles/2020/jan/09/us-fda-approves-blueprints-therapy-for-rare-type-of-stomach-cancer/973051/?refer-section=health 

4) Abbott gets USFDA nod for less-invasive surgical approach for heart   

     pump

Source:  

https://business.medicaldialogues.in/abbott-gets-usfda-nod-for-less-invasive-surgery-for-heart-pump

5) Merck's Keytruda wins U.S. FDA approval for bladder cancer

Source: 

https://www.nasdaq.com/articles/mercks-keytruda-wins-u.s.-fda-approval-for-bladder-cancer-2020-01-08-0